NCT03742726

Study Assessing the Safety and Performance of Smart Matrix®

Study Assessing the Safety and Performance of Smart Matrix® Dermal Replacement Scaffold in the Treatment of Full-Thickness Wounds Arising From Surgical Excision of Basal Cell or Squamous Cell Carcinomas in Male and Female Adult Patients

• Status: Unknown
• Phase: N/A
• Study type: Interventional
• Enrollment: 32 (actual)
• Sponsor: Smart Matrix Limited · Academic / Other
• Sex: All
• Age: 18 Years – 90 Years
• Healthy volunteers: Not accepted

Summary

Smart Matrix is a sterile, single layer dermal replacement scaffold. The scaffold consists of a porous matrix of cross-linked human fibrin plus alginate that has been designed and optimised to facilitate wound closure and healing through cellular invasion.

Conditions

• Basal Cell Carcinoma
• Squamous Cell Carcinoma

Interventions

Type	Name	Description
DEVICE	Smart Matrix scaffold	Smart Matrix dermal replacement scaffold

Timeline

• Start date: 2018-10-12
• Primary completion: 2021-07-01
• Completion: 2022-01-01
• First posted: 2018-11-15
• Last updated: 2021-02-21

Locations

4 sites across 1 country: United Kingdom